Leo Silva’s GD2 CAR-T Cell Therapy Journey for High-Risk Neuroblastoma

If you looked at my phone's browser history from last October, you would just see the same terrifying words typed over and over again.

Neuroblastoma relapse.

High-risk neuroblastoma survival.

What happens when chemo stops working for a child?

I didn't know anything about advanced cellular therapies. I had never even heard the acronym "CAR-T" in my entire life. I was just a desperate mother in São Paulo trying to figure out how to save her seven-year-old son.

Leo had already gone through two years of hell. We did the heavy chemotherapy, the surgeries to remove what they could, and the endless weeks confined to a pediatric oncology ward.

For a few months, his scans were clear. Then, the bone marrow pain started again.

The local doctors were devastated to tell us that the cancer had mutated and returned. His tiny body was rejecting the standard protocols, and we were officially out of local medical options.

I started searching for the disease, not the cure

When you are told your child has exhausted all treatments, you do not just go home and accept it.

I stopped taking on graphic design clients and treated internet research like a full-time job. I joined every international parent support group I could find for neuroblastoma.

I was just looking for a reason not to give up.

In one of those deep, late-night forum threads, another parent mentioned that their child was receiving something called "immunotherapy" for a relapsed solid tumor. That was the very first time I saw the words CAR-T Cell Therapy.

I spent the next three days reading everything I could understand about it.

It is a highly complex science, but the way a parent explained it to me finally made sense. She broke it down into three basic steps, which is exactly how I explain it to my family today:

• The Extraction: They take blood from the patient and filter out the T-cells, which are the natural immune system cells that fight off regular viruses.
• The Reprogramming: In a laboratory, they alter the DNA of these T-cells. They add a special receptor (the CAR) that is designed to hunt for a very specific protein. For neuroblastoma, that protein is called GD2.
• The Attack: Millions of these newly modified cells are put back into the child. Now, instead of ignoring the cancer, the immune system recognizes the GD2 protein on the tumors and attacks it relentlessly.

It felt like science fiction. But the more I researched, the more real it became.

Moving our entire life to Beijing, China

The biggest problem was access. This type of highly targeted GD2 therapy was not available anywhere near us in South America. Through my frantic networking, I found out about Bioocus Medical Group in Beijing. They were leading major advancements in cellular immunotherapy, specifically for pediatric cancers that had failed other treatments.

I was completely overwhelmed by the idea of applying to a hospital in China. I found PlacidWay while searching for international medical treatment advice. They actually stepped in and helped coordinate the transfer of Leo’s massive, translated medical files straight to the oncology team at Bioocus Medical Group. Having someone just manage the document portal meant I could focus entirely on holding my son together.

"We took a leap of absolute faith. We packed two suitcases, boarded a flight that took over twenty-four hours, and carried our sick little boy to a country where we didn't speak a single word of the language."

When we finally arrived at the clinic in Beijing, the multilingual staff was incredible.

They ran an immediate, free evaluation based on his new lab work. The international medical team sat us down and confirmed that Leo was a candidate for the GD2 CAR-T cells.

Making room for the new engineered cells

The actual treatment process was completely different from what I expected.

First, they had to collect his T-cells through a machine that filters his blood, which took a few hours. Then, we had to wait while the laboratory spent days engineering his cells into cancer-hunting weapons.

Right before the new cells were ready, Leo had to undergo preconditioning.

This meant a few days of specific chemotherapy drugs fludarabine and cyclophosphamide. The doctors explained it wasn't to shrink the tumor, but to temporarily suppress his tired immune system so his body wouldn't reject the modified CAR-T cells.

He was so weak during those days in the Beijing hospital room. He just wanted to sleep and hold his favorite blanket.

Waiting for the fever that proved it was working

The infusion itself took almost no time.

A nurse brought in a small IV bag of fluid containing his engineered cells. It dripped into his port, and just like that, his reprogrammed immune system was inside him.

The medical team warned us that the real danger happens as the cells start multiplying and attacking the cancer.

They told us to watch for a fever. An immune response is violent, and the body reacts exactly like it is fighting off a massive infection.

On day five, his temperature spiked. He was miserable, exhausted, and required round-the-clock monitoring by the Bioocus Medical Group staff to ensure his organs weren't under too much stress.

By day ten, his bloodwork showed that the CAR-T cells had expanded beautifully.

Bringing our boy back home to South America

We stayed in China for several more weeks to ensure he was stable.

The day we finally got his follow-up MRI results, I couldn't stop crying. The oncologist pointed to the screen, showing us that the primary tumor had shrunk significantly.

More importantly, the bone marrow biopsies showed that the cancer was clearing out. His body was doing exactly what the science promised it would do.

We are back in São Paulo now.

Leo is still recovering. This is not a magic wand. His immune system is very fragile, and he gets tired easily just walking around the living room.

We still hold our breath before every single blood test.

But last night, I watched him sit on the floor and build an entire spaceship out of building blocks. He hasn't had the energy to do that in over a year.

Disclaimer: This article is a fictionalized narrative based on a composite patient persona. The timeline, emotional experiences, and events are structurally invented to illustrate a potential patient journey. This story does not represent the verified testimony of a real individual, nor does it guarantee specific outcomes, pricing, or medical results from the mentioned provider. It is not intended as medical advice. Always consult with a qualified healthcare professional regarding treatment decisions and the risks associated with experimental or advanced cellular therapies.